Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment
Biomolecules · 2024
DOI: 10.3390/biom14080960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Yunan Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Drug Delivery Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine, Postgraduate Scientific Research Innovation Project of Hunan Province.
Abstract (Originalsprache)
Cardiovascular diseases (CVDs) are one of the leading causes of death worldwide. Despite significant advances in current drug therapies, issues such as poor drug targeting and severe side effects persist. In recent years, nanomedicine has been extensively applied in the research and treatment of CVDs. Among these, biomembrane-modified biomimetic nanodrug delivery systems (BNDSs) have emerged as a research focus due to their unique biocompatibility and efficient drug delivery capabilities. By modifying with biological membranes, BNDSs can effectively reduce recognition and clearance by the immune system, enhance biocompatibility and circulation time in vivo, and improve drug targeting. This review first provides an overview of the classification and pathological mechanisms of CVDs, then systematically summarizes the research progress of BNDSs in the treatment of CVDs, discussing their design principles, functional characteristics, and clinical application potential. Finally, it highlights the issues and challenges faced in the clinical translation of BNDSs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
- School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
ORCID-Profile: Ya Li
Förderung
- National Natural Science Foundation of China
- Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine
- Postgraduate Scientific Research Innovation Project of Hunan Province
- Hunan University students innovation and entrepreneurship training program
- Scientific Research Topics of Hunan Provincial Health and Wellness Commission
- Hunan University of Chinese Medicine 2023 Provincial Undergraduate Innovation and Entrepreneurship Training Program Project
Zitieren
APA
Gu, Y., Du, L., Wu, Y., Qin, J., Gu, X., Guo, Z., & Li, Y. (2024). Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment. Biomolecules. https://doi.org/10.3390/biom14080960
Vancouver
Gu Y, Du L, Wu Y, Qin J, Gu X, Guo Z, et al. Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment. Biomolecules. 2024. doi:10.3390/biom14080960
BibTeX
@article{Gu2024,
author = {Gu, Yunan and Du, Lixin and Wu, Yuxin and Qin, Juan and Gu, Xiang and Guo, Zhihua and Li, Ya},
title = {Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14080960}
}
EUVIMED